Literature DB >> 7771666

Variation in the association of alcohol consumption with five DSM-IV alcohol problem domains.

D A Dawson1, B F Grant, T C Harford.   

Abstract

Data from a nationally representative sample of the U.S. adult population were used to investigate the association between alcohol consumption and five discrete problem domains included in the DSM-IV formulations for alcohol abuse and dependence. Two dimensions of consumption were considered in the analysis: average daily ethanol intake and the relative frequency of drinking five or more drinks. The sample consisted of 22,102 adults defined as current drinkers. After controlling for various sociodemographic characteristics, family history of alcoholism, and age at onset of drinking, both consumption measures retained significant levels of association within all five problem domains. The magnitudes of the odds ratios at selected levels of consumption were approximately 50% greater for the domains of impaired control, continued drinking despite problems and hazardous drinking than for the domains of tolerance and withdrawal. Moreover, the factors that modified the effect of the consumption measures varied markedly across domains, with age, college education, and race the most consistent modifiers of the effect of alcohol consumption.

Entities:  

Mesh:

Year:  1995        PMID: 7771666

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  11 in total

1.  Onset and course of alcoholism over 25 years in middle class men.

Authors:  Marc A Schuckit; Tom L Smith
Journal:  Drug Alcohol Depend       Date:  2010-08-19       Impact factor: 4.492

2.  Modeling the severity of drinking consequences in first-year college women: an item response theory analysis of the Rutgers Alcohol Problem Index.

Authors:  Amy M Cohn; Brett T Hagman; Fiona S Graff; Nora E Noel
Journal:  J Stud Alcohol Drugs       Date:  2011-11       Impact factor: 2.582

3.  High-risk alcohol consumption and late-life alcohol use problems.

Authors:  Rudolf H Moos; Penny L Brennan; Kathleen K Schutte; Bernice S Moos
Journal:  Am J Public Health       Date:  2004-11       Impact factor: 9.308

4.  Drinking despite health problems among individuals with liver disease across the United States.

Authors:  Jennifer C Elliott; Malka Stohl; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2017-05-09       Impact factor: 4.492

5.  [Commentary] Low-risk drinking limits: absolute versus relative risk.

Authors:  Deborah A Dawson
Journal:  Addiction       Date:  2009-08       Impact factor: 6.526

6.  Education and race-ethnicity differences in the lifetime risk of alcohol dependence.

Authors:  S E Gilman; J Breslau; K J Conron; K C Koenen; S V Subramanian; A M Zaslavsky
Journal:  J Epidemiol Community Health       Date:  2008-03       Impact factor: 3.710

7.  Older adults' alcohol consumption and late-life drinking problems: a 20-year perspective.

Authors:  Rudolf H Moos; Kathleen K Schutte; Penny L Brennan; Bernice S Moos
Journal:  Addiction       Date:  2009-05-12       Impact factor: 6.526

Review 8.  Medical risks for women who drink alcohol.

Authors:  K A Bradley; S Badrinath; K Bush; J Boyd-Wickizer; B Anawalt
Journal:  J Gen Intern Med       Date:  1998-09       Impact factor: 5.128

9.  Screening for problem drinking: comparison of CAGE and AUDIT. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K A Bradley; K R Bush; M B McDonell; T Malone; S D Fihn
Journal:  J Gen Intern Med       Date:  1998-06       Impact factor: 5.128

10.  NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization.

Authors:  Clemens Schotten; Lars P Bechmann; Paul Manka; Jens Theysohn; Alexander Dechêne; Amr El Fouly; Francesco Barbato; Ursula Neumann; Sonia Radünz; Svenja Sydor; Dominik Heider; Marino Venerito; Ali Canbay; Guido Gerken; Ken Herrmann; Heiner Wedemeyer; Jan Best
Journal:  Liver Cancer       Date:  2019-07-29       Impact factor: 11.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.